Cell line (Male/ female) | Mutation | IL1R1 mRNA | IL1Racp mRNA | IDO1 Response to IL-1β | CXCL8 response to IL-1β | |
---|---|---|---|---|---|---|
NSCLC Adenocarcinoma | A549 (M) | KRAS, LKB mutant | + + + + | + + | + + | + + + |
H1792 (M) | KRAS mutant | + + + + | + + + | + + + + + + | + + + + + + | |
H1838 (F) | EGFR Amplification | + + + | + + + | + + | + + | |
H2347 (F) | NRAS mutant | + + + | + + + | + + + | + + + + | |
HCC364 (M) | BRAFV600E mutant | + + + + + | + + + | + + + | + + + + | |
HCC827 (F) | EGFR mutant | + + + | + + + + | + + + + | + + | |
H2228 (F) | EML4-ALK1 fusion | + + + | + + + + + + | - | + + + | |
Immortalized Normal cells | HBEC-3KT | Non-cancerous lung epithelial cells Immortalized with CDK4 and hTERT | + | + + + + | - | + |
HSAEC-1KT | Non-cancerous lung epithelial cells Immortalized with CDK4 and hTERT | - | + |